Home
Posts
More on the Tax-Cuts-and-Medicaid-Cuts Bill, Including an Apex Analysis of a Biotech-Boosting R&D Tax Provision

More on the Tax-Cuts-and-Medicaid-Cuts Bill, Including an Apex Analysis of a Biotech-Boosting R&D Tax Provision

Plus two academic papers worth reading, one raising concerns about step therapy and one raising concerns about MFN. Lots to be concerned about today!

Jul 8, 2025

Subscribe to Cost Curve Apex to read the rest.

Upgrade to Apex to get access to this post and other subscriber-only content.

No posts found